61. Arthur M, Depardieu F, Molinas C, Reynolds P, Courvalin P. The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin. Gene 1995; 154:87-92; PMID:7867956; http://dx.doi.org/10.1016/0378-1119(94)00851-I 62. Ribeiro T, Santos S, Marques MI, Gilmore M, de Fátima Silva Lopes M. Identification of a new gene, vanV, in vanB operons of Enterococcus faecalis. Int J Antimicrob Agents 2011; 37:554-7; PMID:21482081; http://dx.doi.org/10.1016/j.ijantimicag.2011.01.024 63. Arthur M, Molinas C, Courvalin P. The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 1992; 174:2582-91; PMID:1556077 64. Gagnon S, Lévesque S, Lefebvre B, Bourgault AM, Labbé AC, Roger M. vanA-containing Enterococcus faecium susceptible to vancomycin and teicoplanin because of major nucleotide deletions in Tn1546. J Antimicrob Chemother 2011; 66:2758-62; PMID: 21926081; http://dx.doi.org/10.1093/jac/dkr379 65. Choi HJ, Nam D, Peck KR, Song JH, Shin D, Ko KS. Loss of vancomycin resistance not completely dependent on the Tn1546 element in Enterococcus faecium isolates. Diagn Microbiol Infect Dis 2011; 69: 105-10; PMID:21146722; http://dx.doi.org/10.1016/ j.diagmicrobio.2010.08.030 66. Fines M, Perichon B, Reynolds P, Sahm DF, Courvalin P. VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob Agents Chemother 1999; 43:2161-4; PMID:10471558 67. Lebreton F, Depardieu F, Bourdon N, Fines-Guyon M, Berger P, Camiade S, et al. D-Ala-d-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother 2011; 55: 4606-12; PMID:21807981; http://dx.doi.org/10. 1128/AAC.00714-11 68. McKessar SJ, Berry AM, Bell JM, Turnidge JD, Paton JC. Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis. Antimicrob Agents Chemother 2000; 44:3224-8; PMID:11036060; http://dx.doi.org/10.1128/AAC. 44.11.3224-3228.2000 69. Xu X, Lin D, Yan G, Ye X, Wu S, Guo Y, et al. vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium. Antimicrob Agents Chemother 2010; 54:4643-7; PMID:20733041; http://dx.doi.org/ 10.1128/AAC.01710-09 70. Werner G, Freitas AR, Coque TM, Sollid JE, Lester C, Hammerum AM, et al. Host range of enterococcal vanA plasmids among Gram-positive intestinal bacteria. J Antimicrob Chemother 2011; 66:273-82; PMID: 21131318; http://dx.doi.org/10.1093/jac/dkq455 71. Foucault ML, Courvalin P, Grillot-Courvalin C. Fitness cost of VanA-type vancomycin resistance in methicillin- resistant Staphylococcus aureus. Antimicrob Agents Chemother 2009; 53:2354-9; PMID:19332680; http://dx.doi.org/10.1128/AAC.01702-08 72. Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan SE, et al. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 2003; 302:1569-71; PMID:14645850; http:// dx.doi.org/10.1126/science.1090956 73. de Niederhäusern S, Bondi M, Messi P, Iseppi R, Sabia C, Manicardi G, et al. Vancomycin-resistance transfer- ability from VanA enterococci to Staphylococcus aureus. Curr Microbiol 2011; 62:1363-7; PMID:21234755; http://dx.doi.org/10.1007/s00284-011-9868-6 74. Zhu W, Murray PR, Huskins WC, Jernigan JA, McDonald LC, Clark NC, et al. Dissemination of an Enterococcus Inc18-Like vanA plasmid associated with vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2010; 54:4314-20; PMID: 20660665; http://dx.doi.org/10.1128/AAC.00185-10 75. Leclercq R, Dutka-Malen S, Duval J, Courvalin P. Vancomycin resistance gene vanC is specific to Enterococcus gallinarum. Antimicrob Agents Chemother 1992; 36:2005-8; PMID:1416893 76. Navarro F, Courvalin P. Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens. Antimicrob Agents Chemother 1994; 38:1788-93; PMID:7986009 77. Arias CA, Courvalin P, Reynolds PE. vanC cluster of vancomycin-resistant Enterococcus gallinarum BM4174. Antimicrob Agents Chemother 2000; 44: 1660-6; PMID:10817725; http://dx.doi.org/10.1128/ AAC.44.6.1660-1666.2000 78. Guardabassi L, Christensen H, Hasman H, Dalsgaard A. Members of the genera Paenibacillus and Rhodococcus harbor genes homologous to enterococ- cal glycopeptide resistance genes vanA and vanB. Antimicrob Agents Chemother 2004; 48:4915-8; PMID:15561881; http://dx.doi.org/10.1128/AAC. 48.12.4915-4918.2004 79. Guardabassi L, Agersø Y. Genes homologous to glycopeptide resistance vanA are widespread in soil microbial communities. FEMS Microbiol Lett 2006; 259:221-5; PMID:16734783; http://dx.doi.org/10. 1111/j.1574-6968.2006.00270.x 80. Patel R, Piper K, Cockerill FR, 3rd, Steckelberg JM, Yousten AA. The biopesticide Paenibacillus popilliae has a vancomycin resistance gene cluster homologous to the enterococcal VanA vancomycin resistance gene cluster. Antimicrob Agents Chemother 2000; 44:705- 9; PMID:10681342; http://dx.doi.org/10.1128/AAC. 44.3.705-709.2000 81. Stinear TP, Olden DC, Johnson PD, Davies JK, Grayson ML. Enterococcal vanB resistance locus in anaerobic bacteria in human faeces. Lancet 2001; 357: 855-6; PMID:11265957; http://dx.doi.org/10.1016/ S0140-6736(00)04206-9 82. Tsvetkova K, Marvaud JC, Lambert T. Analysis of the mobilization functions of the vancomycin resistance transposon Tn1549, a member of a new family of conjugative elements. J Bacteriol 2010; 192:702-13; PMID:19966009; http://dx.doi.org/10.1128/JB. 00680-09 83. Galloway-Peña J, Roh JH, Latorre M, Qin X, Murray BE. Genomic and SNP analyses demonstrate a distant separation of the hospital and community-associated clades of Enterococcus faecium. PLoS One 2012; 7: e30187; PMID:22291916; http://dx.doi.org/10.1371/ journal.pone.0030187 84. McDonald LC, Rossiter S, Mackinson C, Wang YY, Johnson S, Sullivan M, et al. Quinupristin-dalfopris- tin-resistant Enterococcus faecium on chicken and in human stool specimens. N Engl J Med 2001; 345: 1155-60; PMID:11642231; http://dx.doi.org/10. 1056/NEJMoa010805 85. Raad II, Hanna HA, Hachem RY, Dvorak T, Arbuckle RB, Chaiban G, et al. Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin- dalfopristin. Antimicrob Agents Chemother 2004; 48: 3583-5; PMID:15328133; http://dx.doi.org/10.1128/ AAC.48.9.3583-3585.2004 86. Hammerum AM, Flannagan SE, Clewell DB, Jensen LB. Indication of transposition of a mobile DNA element containing the vat(D) and erm(B) genes in Enterococcus faecium. Antimicrob Agents Chemother 2001; 45:3223-5; PMID:11600385; http://dx.doi.org/ 10.1128/AAC.45.11.3223-3225.2001 87. Jensen LB, Hammerum AM, Aarestrup FM. Linkage of vat(E) and erm(B) in streptogamin-resistant Enterococcus faecium isolates from Europe. Antimicrob Agents Chemother 2000; 44:2231-2; PMID:11023445; http://dx.doi.org/10.1128/AAC. 44.8.2231-2232.2000 88. Jensen LB, Hammerum AM, Aerestrup FM, van den Bogaard AE, Stobberingh EE. Occurrence of satA and vgb genes in streptogramin-resistant Enterococcus faecium isolates of animal and human origins in the Netherlands. Antimicrob Agents Chemother 1998; 42: 3330-1; PMID:10049241 89. Bozdogan B, Leclercq R. Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus fae- cium. Antimicrob Agents Chemother 1999; 43:2720- 5; PMID:10543753 90. Bozdogan B, Leclercq R, Lozniewski A, Weber M. Plasmid-mediated coresistance to streptogramins and vancomycin in Enterococcus faecium HM1032. Antimicrob Agents Chemother 1999; 43:2097-8; PMID:10484759 91. Hershberger E, Donabedian S, Konstantinou K, Zervos MJ. Quinupristin-dalfopristin resistance in gram-positive bacteria: mechanism of resistance and epidemiology. Clin Infect Dis 2004; 38:92-8; PMID: 14679454; http://dx.doi.org/10.1086/380125 92. Jung YH, Shin ES, Kim O, Yoo JS, Lee KM, Yoo JI, et al. Characterization of two newly identified genes, vgaD and vatH, [corrected] conferring resistance to streptogramin A in Enterococcus faecium. Antimicrob Agents Chemother 2010; 54:4744-9; PMID: 20713681; http://dx.doi.org/10.1128/AAC.00798-09 93. Meka VG, Gold HS. Antimicrobial resistance to linezolid. Clin Infect Dis 2004; 39:1010-5; PMID: 15472854; http://dx.doi.org/10.1086/423841 94. Pogue JM, Paterson DL, Pasculle AW, Potoski BA. Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2007; 28:1382-8; PMID:17994519; http://dx.doi.org/10. 1086/523276 95. Lee ZM, Bussema C, 3rd, Schmidt TM. rrnDB: documenting the number of rRNA and tRNA genes in bacteria and archaea. Nucleic Acids Res 2009; 37 (Database issue):D489-93; PMID:18948294; http:// dx.doi.org/10.1093/nar/gkn689 96. Marshall SH, Donskey CJ, Hutton-Thomas R, Salata RA, Rice LB. Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother 2002; 46:3334-6; PMID:12234875; http://dx.doi.org/10.1128/AAC. 46.10.3334-3336.2002 97. Mendes RE, Deshpande LM, Castanheira M, DiPersio J, Saubolle MA, Jones RN. First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States. Antimicrob Agents Chemother 2008; 52:2244-6; PMID: 18391032; http://dx.doi.org/10.1128/AAC.00231-08 www.landesbioscience.com Virulence 431